Ohsu Knight Cancer Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Y-90 Versus SBRT for Inoperable HCC
Phase 2
Withdrawn
- Conditions
- Stage I Hepatocellular Carcinoma AJCC v8Stage IA Hepatocellular Carcinoma AJCC v8Stage IB Hepatocellular Carcinoma AJCC v8Hepatocellular CarcinomaStage II Hepatocellular Carcinoma AJCC v8Stage III Hepatocellular Carcinoma AJCC v8Stage IVA Hepatocellular Carcinoma AJCC v8Stage IIIB Hepatocellular Carcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8
- First Posted Date
- 2021-12-15
- Last Posted Date
- 2023-03-23
- Lead Sponsor
- OHSU Knight Cancer Institute
- Registration Number
- NCT05157451
Pain Management for Head and Neck Cancer Survivors
Not Applicable
Active, not recruiting
- Conditions
- Head and Neck Carcinoma
- First Posted Date
- 2021-11-10
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05115825
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
🇺🇸Portland VA Medical Center, Portland, Oregon, United States
Telehealth & HPV Self-Collection
Not Applicable
Completed
- Conditions
- Gynecologic Cancer
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2023-08-16
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 131
- Registration Number
- NCT05089825
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer
Recruiting
- Conditions
- Stage II Rectal Cancer AJCC v8Stage IIIC Rectal Cancer AJCC v8Rectal AdenocarcinomaStage IIA Rectal Cancer AJCC v8Stage III Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8Stage IIIA Rectal Cancer AJCC v8Stage IIIB Rectal Cancer AJCC v8
- First Posted Date
- 2021-10-18
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 50
- Registration Number
- NCT05081024
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients
Not Applicable
Withdrawn
- Conditions
- Breast CarcinomaRadiation-Induced DermatitisHead and Neck Carcinoma
- Interventions
- Drug: Silicone-based Film Forming Topical GelOther: Petrolatum-Mineral Oil-Lanolin-Ceresin OintmentOther: Polyethylene Glycol Hydrogel
- First Posted Date
- 2021-10-11
- Last Posted Date
- 2024-05-06
- Lead Sponsor
- OHSU Knight Cancer Institute
- Registration Number
- NCT05073172
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Calaspargase Pegol-Mnkl and Cobimetinib for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer
Phase 1
Recruiting
- Conditions
- Stage II Pancreatic Cancer AJCC v8Stage IV Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Locally Advanced Pancreatic AdenocarcinomaMetastatic Pancreatic AdenocarcinomaStage IIB Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8
- Interventions
- First Posted Date
- 2021-09-05
- Last Posted Date
- 2024-10-28
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 15
- Registration Number
- NCT05034627
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Effects of Simulated Solar Radiation on Human Skin in Preventing Skin Cancer
Not Applicable
Completed
- Conditions
- Melanoma
- First Posted Date
- 2021-08-30
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 6
- Registration Number
- NCT05027009
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Humidified Forest Oils for Immune System Recovery in Stage I-III Breast or Prostate Cancer
Not Applicable
Active, not recruiting
- Conditions
- Prostate CarcinomaBreast Carcinoma
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 30
- Registration Number
- NCT05012813
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
MammoScreen Breast Cancer Risk Assessment and Decision Aid for Breast Cancer Screening and Referrals
- Conditions
- Breast Carcinoma
- First Posted Date
- 2021-08-09
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 1141
- Registration Number
- NCT04996316
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
Standard Verbal Counseling With or Without a Pictorial Educational Tool for the Reduction of Psychological Morbidity in Patients With Stage 0-IIIA Breast Cancer Receiving Radiation Therapy, COPE Study
Not Applicable
Active, not recruiting
- Conditions
- Prognostic Stage I Breast Cancer AJCC v8Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Prognostic Stage IIA Breast Cancer AJCC v8Prognostic Stage IIIA Breast Cancer AJCC v8Prognostic Stage II Breast Cancer AJCC v8Anatomic Stage 0 Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- OHSU Knight Cancer Institute
- Target Recruit Count
- 62
- Registration Number
- NCT04993313
- Locations
- 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States